IPTLD®

Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D. IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

Tuesday, February 18, 2014

FRAGMENT FROM THE ARTICLE PUBLISHED IN THE NEW YORK TIMES:The
New York Times reports that the study, published on Tuesday in the
British Medical Journal, has shaken the medical community in part
because it’s one of the most thorough studies of the procedure to
date.“Researchers tracked more than 89,835 Canadian women, half of whom
were randomly assigned to mammogram screenings. The other half had no
mammograms and performed breast exams on themselves.Twenty-five years
later, the researchers found an identical rate of breast-cancer deaths
in both groups. The mammograms’ only discernible impact was to elevate
the diagnosis rate by 22%, or “overdiagnose” patients who were suffering
from nonlethal forms of cancer and therefore could have avoided
surgeries, chemotherapy and radiation treatments”.

Twenty
five year follow-up for breast cancer incidence and mortality of the
Canadian National Breast Screening Study: randomised screening trial.BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g366 (Published 11 February 2014)Cite this as: BMJ 2014;348:g366Conclusion
Annual mammography in women aged 40-59 does not reduce mortality from
breast cancer beyond that of physical examination or usual care when
adjuvant therapy for breast cancer is freely available. Overall, 22%
(106/484) of screen detected invasive breast cancers were
over-diagnosed, representing one over-diagnosed breast cancer for every
424 women who received mammography screening in the trial.

Dr.Donato's
opinion: Do we have something better? Most likely yes and less damaging
to the breast tissue, consider Breast Thermography: simple and
reliable. Also if breast mammography screening is failing, current
medical treatments are not addressing the breast cancer properly. There
is no treatment that can guarantee a cure. Cancer can be effectively
controlled when the treatment is the right one for the patients clinical
condition. Insulin Potentiation Therapy + targeted Low Dose IPTLD® or
IPT, is a cancer treatment alternative. It uses a combination of two
orthodox drugs - insulin (actually insulin is also found in nature) and a
chemotherapy drug combination. Cancer cells have highly active insulin
receptors.

With
IPTLD® the insulin works on the cell membranes and allows chemotherapy
to target cancer cells. Thus, it is the chemotherapy that kills the
cancer cells, however, because of the insulin, the amount of
chemotherapy needed is greatly reduced, meaning the side-effects of the
chemotherapy are greatly reduced. Thus, the chemotherapy is much more
potent (thus the word: potentiation), much less chemotherapy is needed,
and far less side-effects are experienced.

Insulin
is truly a "magic bullet" cancer treatment, meaning it allows
chemotherapy to target cancer cells and results in far less
side-effects.

The
word "potentiate" means that one substance (insulin) enhances the
effectiveness of another agent (chemotherapy) and thus far less of the
second agent (chemotherapy) is needed. This means far less side-effects,
as well as a more effective treatment, is the result of a potentiating
substance.Not only is IPTLD more effective than normal chemotherapy, it can be administered more frequenly, but with less side-effects.Consider
the following doses of chemotherapy required by orthodox medicine
versus IPTLD therapists (i.e. orthodox dose to IPTLD dose):

Using
insulin is safe as long as the physician administering the treatment
has been properly trained and has a valid certification. Since the early
discovery IPT has been a safe treatment that controls cancer for longer
periods (+ 10 yeas or more). Since IPTLD® works there are several
physicians claiming their expertise, BEWARE not all have been properly
trained or continued with their education. For a list of Certified
IPT/IPTLD® practitioners endorsed by Donato Perez Garcia,MD go to: http://findaniptldphysician.blogspot.mx/For more information on I.P.T. visit: www.iptldmd.comwww.donatoperezgarcia.com